Recently, drug repurposing has emerged as a feasible strategy to overcome ABCB1- or ABCG2-mediated drug resistance in cancer (Wang et al., 2020a; Zhang et al., 2020; Wu et al., 2022). The gene discussed is ABCB1; the disease is cancer.